Discovery and characterization of ß-1,6-glucan inhibitors

Expert Opinion on Drug Discovery

Volumn 5, Issue 8, 2010, Pages 739-749

  Kitamura, Akihiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

1; 6 glucan; Antifungal; Cell wall; D75 4590

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,6 GLUCAN INHIBITOR; D 112040; D 216076; D 754590; D 75459O; UNCLASSIFIED DRUG;

CELL WALL; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGAL CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW;

ANTIFUNGAL AGENTS; BETA-GLUCANS; CELL WALL; FUNGI; HUMANS; MYCOSES; OPPORTUNISTIC INFECTIONS;

EID: 77954771585     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2010.498472     Document Type: Review

References (73)

1. Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol 2006;55:809-818
2. Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy 2004;2:4S-28S
3. Zaoutis TE, Argon J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:1232-1239
4. Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gap in coverage. Clin Infect Dis 2006;43:1060-1068
5. Segal BH, Almyroudis NG, Battiwalla M, et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007;44:402-409
6. Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-1066
7. Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005;43:4434-4440
8. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 2007;10:121-130
9. Hakki M, Staab JF, Marr KA. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy. Antimicrob Agets Chemother 2006;50:2522-2524
10. Moudgal V, Little T, Boikov D, et al. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agets Chemother 2005;49:767-769
11. Lesage G, Bussey H. Cell wall assembly in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2006;70:317-343
12. Klis FM, Boorsma A, Groot PWJ. Cell wall construction in Saccharomyces cerevisiae. Yeast 2006;23:185-202
13. Lehle L, Strahl S, Tanner W. Protein glycosylation, conserved from yeast to man. Angew Chem Int Ed 2006;45:6802-6818
14. Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet Mycol 1997;35:79-86
15. Onishi J, Meinz M, Thompson J, et al. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agets Chemother 2000;4:368-377
16. Traxler P, Gruner J, Auden JA. Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E. J Antibiot 1977;30:289-296
17. Gaughran JP, Lai MH, Kirsch DR, et al. Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. J Bacteriol 1994;176:5857-5860
18. Sudoh M, Yamazaki T, Masubuchi K, et al. Identification of a novel inhibitor specific to the fungal chitin synthase. Inhibition of chitin synthase 1 arrests the cell growth, but inhibition of chitin synthase 1 and 2 is lethal in the pathogenic fungus Candida albicans. J Biol Chem 2000;275:32901-32905
19. Shahinian S, Bussey H. beta-1,6-Glucan synthesis in Saccharomyces cerevisiae. Mol Microbiol 2000;35:477-489
20. Vink E, Rodriguez-Suarez RJ, Gerard-Vincent M, et al. An in vitro assay for (1 → 6)-beta-D-glucan synthesis in Saccharomyces cerevisiae. Yeast 2004;21:1121-1131
21. Aimanianda V, Clavaud C, Simenel C, et al. Cell wall beta-(1,6)-glucan of Saccharomyces cerevisiae: structural characterization and in situ synthesis. J Biol Chem 2009;284:13401-13412
22. Meaden P, Hill K, Wanger J, et al. The yeast KRE5 gene encodes a probable endoplasmic reticulum protein required for (1!6) beta-D-glucan synthesis and normal cell growth. Mol Cell Biol 1990;10:3013-3019
23. Romer T, Delaney S, Bussey H. SKN1 and KRE6 define a pair of functional homologs encoding putative membrane proteins involved in beta-glucan synthesis. Mol Cell Biol 1993;13:4039-4048
24. Brown JL, Kossaczka Z, Jiang B, et al. A mutational analysis of killer toxin resistance in Saccharomyces cerevisiae identifies new genes involved in cell wall (1!6) beta- glucan synthesis. Genetics 1993;133:837-849
25. Brown JL, Kossaczka Z, et al. The yeast KRE9 gene encodes an O glycoprotein involved in cell surface beta-glucan assembly. Mol Cell Biol 1993;13:6346-6356
26. Jiang B, Sheraton J, Ram AFJ, et al. CWH41 encode a novel endoplasmic reticulum membrane N-glycoprotein involved in beta1,6-glucan assembly. J Bacteriol 1996;178:1162-1171
27. Dijkgraaf GJP, Brown JL, Bussey H. The KNH1 gene of Saccharomyces cerevisiae is a functional homolog of KRE9. Yeast 1996;12:683-692
28. Roemer T, Bussey H. Yeast beta-glucan synthesis: KRE6 encodes a predicted type II membrane protein required for glucan synthesis in vivo and for glucan synthase activity in vitro. Proc Natl Acad Sci 1991;88:11295-11299
29. Roemer T, Paravicini G, Payton MA, et al. Characterization of the yeast (1!6) beta-glucan biosynthetic components, Kre6p and Skn1p, and genetic interaction between the PKC1 pathway and extracellular matrix assembly. J Cell Biol 1994;127:567-569
30. Nakamata K, Kurita T, Bhuiyan MSA, et al. KEG1/YFR042w encodes a novelKre6-binding endoplasmic reticulum membrane protein responsible for beta-1,6-glucan synthesis in Saccharomyces cerevisiae. J Biol Chem 2007;282:34315-34324
31. Kollar R, Reinhold BB, Petrakova E, et al. Architecture of the yeast cell wall. J Biol Chem 1997;272:17762-17775
32. Ferguson MAJ, Williams AF. Cell-surface anchoring of proteins via glycosyl-phosphatidyl -inositol structures. Ann Rev Biochem 1988;57:285-320
33. Lu CF, Kurjan J, Lipke PN. A pathway for cell wall anchorage of Saccharomyces cerevisiae alpha-agglutinin. Mol Cell Biol 1994;14:4825-4833
34. Hamada K, Terashima H, Arisawa M, et al. Amino acid sequence requirement for efficient incorporation of glycosylphosphatidylinositol-associated proteins into the Cell wall of Saccharomyces cerevisiae. J Biol Chem 1998;273:26946-26953
35. Nosjean O, Briolay A, Roux B. Mammalian GPI protein: sorting, membrane residence and functions. Biochim Biophys Acta 1997;1331:153-186
36. Frieman MB, Cormack BP. Multiple sequence signals determine the distribution of glycosylphosphatidylinositol proteins between the plasma membrane and cell wall in Saccharomyces cerevisiae. Microbiology 2004;150:3105-3114
37. Vaart JMVD, Biesebeke RT, Chapman JW, et al. Comparison of cell wall proteins of Saccharomyces cerevisiae as anchors for cell surface expression of heterologus proteins. Appl Environ Microbiol 1997;63:615-620
38. Kondo A, Ueda M. Yeast cell-surface display-application of molecular display. Appl Microbiol Biotechnol 2004;64:28-40
39. Kitamura A, Someya K, Nakajima R. Method for screening agents acting on cell wall. US20040091949; 2004
40. Kitamura A, Someya K, Hata M, et al. Discovery of a small-molecule inhibitor of beta-1,6-glucan synthesis. Antimicrob Agents Chemother 2008;53:670-677
41. Kitamura A, Higuchi S, Hata M, et al. Effect of beta-1,6-glucan inhibitors on the invasion process of Candida albicans: potential mechanism of their in vivo efficacy. Antimicrob Agents Chemother 2009;53:3963-3971
42. Takemura M, Takahashi H, Kawakami K, et al. Imidazo[1,2-a] pyridine derivatives. US2005113397; 2005
43. Kitamura A, Someya K, Okumura R, et al. In vitro antifungal activities of D11-2040, a beta-1,6-glucan inhibitor, with or without currently available antifungal drugs. Biol Pharm Bull 2010;33:192-197
44. Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, et al. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 2002;46:2477-2481
45. DDBJ, GenBank, and EMBL database
46. Henry C, Mouya I, Latge JP. Testing the efficacy of RNA interference constructs in Aspergillus fumigatus. Curr Genet 2007;51:277-284
47. Nakamata K, Kurita T, Bhuiyan MS, et al. KEG1/YFR042w encodes a novel Kre6-binding endoplasmic reticulum membrane protein responsible for beta-1,6-glucan synthesis in Saccharomyces cerevisiae. J Biol Chem 2007;282:34315-34324
48. Mio T, Okabe TY, Yabe T, et al. Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function. J Bacteriol 1997;179:2363-2372
49. Fontaine T, Simenel C, Dubreucq G, et al. Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. J Biol Chem 2000;275:27594-27607
50. Brul S, King A, van der Vaart JM, et al. The incorporation of mannoproteins in the cell wall of S. cerevisiae and filamentous Ascomycetes. Antonie Van Leeuwenhoek 1997;72:229-237
51. Schoffelmeer EA, Kapten JC, Montijin RC, et al. Glucosylation of fungal proteins as potential target for novel antifungal agents. In: Lyr H, Russel PE, Sisler HD (Eds). Modern fungicides and antifungal compounds. Intercept Ltd., Hampshire, UK 1996;157-162
52. Siafakas AR, Sorrell TC, Wright LC, et al. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J Biol Chem 2007;52:37508-37514
53. Mavor AL, Thewes S, Hube B. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 2005;6:863-874
54. Hoyer LL, Green CB, et al. Discovering the secrets of the Candida albicans Agglutinin-like sequence (ALS) gene family-a sticky pursuit. Med Mycol 2008;46:1-15
55. Argimon S, Wishart JA, Leng R, et al. Developmental regulation of an adhesingene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot Cell 2007;6:682-692
56. Staab JF, Bradway SD, Fidel PL, et al. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999;283:1535-1538
57. Nobile CJ, Nett JE, Andes DR, et al. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006;10:1604-1610
58. Albrecht A, Felk A, Pichova I, et al. Glycosylphosphatidylinositol- anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem 2006;281:688-694
59. Theiss S, Ishdorj G, Brenot A, et al. Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence. Int J Med Microbiol 2006;296:405-420
60. Naglik JR, Newport G, White TC, et al. Differential expression of Candida albicans secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 1999;67:2482-2490
61. Cheng S, Clancy CJ, Checkley MA, et al. Identification of Candida albicans genes induced during thrush offers insight into pathogenesis. Mol Microbiol 2003;48:1275-1288
62. Chang G, Wozniak K, Wallig MA, et al. Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis. Infect Immun 2005;73:1656-1663
63. Dranginis AM, Rauceo JM, Coronado JE, et al. A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol Mol Biol Rev 2007;71:282-294
64. Cormack BP, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 1999;285:578-582
65. de Groot PW, Kranveld EA, Yin QY, et al. The cell wall of the human pathogen Candida glabrata: Differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 2008;7:1951-1964
66. Chayakulkeeree M, Sorrell TC, Siafakas AR, et al. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virlence of Cryptococcus neoformans. Mol Microbiol 2008;69:809-826
67. Gauwerky K, Borelli C, Korting HC. Targeting virulence: a new paradigm for antifungals. Drug Discov Today 2009;14:214-222
68. Nobile CJ, Schneider HA, Nett JE, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 2008;18:1017-1024
69. Zhang M, Liang Y, Zhang X, et al. Deletion of yeast CWP genes enhances cell permeability to genotoxic agents. Toxicol Sci 2008;103:68-76
70. Aoki K, Uchiyama R, Yamauchi S, et al. Newly discovered neutral glycosphingolipids in aureobasidin A-resistant zygomycetes: identification of a novel family of Gala-series glycolipids with core Gal alpha 1-6Gal beta 1-6Gal beta sequences. J Biol Chem 2004;279:32028-32034
71. Umemura M, Okamoto M, Nakayama K, et al. GWT1 gene is required for inositol acylation of glycosylphosphatidylinositol anchors in yeast. J Biol Chem 2003;278:23639-23647
72. Justice MC, Ku T, Hsu MJ, et al. Mutations in ribosomal protein L10e confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin. J Biol Chem 1999;274:4869-4875
73. Kurachi T, Morita I, Oki T, et al. Expression on outer membranes of mannose residues, which are involved in osteoclast formation via cellular fusion events. J Bio Chem 1994;269:17572-17576